Orgel Wealth Management LLC Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Orgel Wealth Management LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 764 shares of the healthcare conglomerate’s stock after selling 138 shares during the period. Orgel Wealth Management LLC’s holdings in UnitedHealth Group were worth $284,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Dividend Assets Capital LLC boosted its position in UnitedHealth Group by 17.0% in the 1st quarter. Dividend Assets Capital LLC now owns 10,236 shares of the healthcare conglomerate’s stock valued at $3,809,000 after buying an additional 1,487 shares during the period. Park Avenue Securities LLC raised its holdings in shares of UnitedHealth Group by 11.7% in the 1st quarter. Park Avenue Securities LLC now owns 25,966 shares of the healthcare conglomerate’s stock valued at $9,661,000 after purchasing an additional 2,721 shares in the last quarter. JJJ Advisors Inc. raised its stake in UnitedHealth Group by 52.7% during the 1st quarter. JJJ Advisors Inc. now owns 397 shares of the healthcare conglomerate’s stock worth $148,000 after acquiring an additional 137 shares in the last quarter. Minneapolis Portfolio Management Group LLC raised its stake in UnitedHealth Group by 1.1% during the 1st quarter. Minneapolis Portfolio Management Group LLC now owns 104,852 shares of the healthcare conglomerate’s stock worth $39,012,000 after acquiring an additional 1,166 shares in the last quarter. Finally, Lindbrook Capital LLC raised its stake in UnitedHealth Group by 9.2% during the 1st quarter. Lindbrook Capital LLC now owns 1,473 shares of the healthcare conglomerate’s stock worth $548,000 after acquiring an additional 124 shares in the last quarter. 86.03% of the stock is owned by hedge funds and other institutional investors.

In related news, CAO Thomas E. Roos sold 5,301 shares of the firm’s stock in a transaction that occurred on Tuesday, April 27th. The shares were sold at an average price of $394.66, for a total transaction of $2,092,092.66. Following the transaction, the chief accounting officer now owns 58,589 shares of the company’s stock, valued at $23,122,734.74. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the transaction, the chief accounting officer now directly owns 31,908 shares in the company, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. Insiders sold 20,420 shares of company stock valued at $7,532,962 over the last three months. 0.80% of the stock is owned by insiders.

Several analysts have recently weighed in on the stock. Credit Suisse Group lifted their target price on shares of UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, April 22nd. BMO Capital Markets boosted their price objective on shares of UnitedHealth Group from $410.00 to $435.00 and gave the stock a “market perform” rating in a report on Thursday, April 22nd. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a report on Thursday, April 22nd. Oppenheimer upped their price target on shares of UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, April 22nd. Finally, Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 price objective for the company in a research report on Tuesday, April 27th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $409.61.

Shares of UNH stock traded up $0.61 during trading hours on Tuesday, reaching $406.51. The stock had a trading volume of 29,765 shares, compared to its average volume of 3,262,127. UnitedHealth Group Incorporated has a twelve month low of $273.71 and a twelve month high of $406.77. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The firm has a 50-day simple moving average of $378.48 and a 200-day simple moving average of $349.25. The firm has a market capitalization of $383.70 billion, a PE ratio of 23.31, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 EPS for the quarter, topping the consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The company had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. During the same period last year, the company posted $3.72 earnings per share. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date was Friday, March 12th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.09%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.

Featured Article: Margin

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.